We are live on ! Find out more
SVNT

SAVIENT PHARMACEUTICALS INC
SVNT

Delisted

SVNT was delisted on the 16th of October, 2013.

Back to rankings

41 hedge funds and large institutions have $13M invested in SAVIENT PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

7% less capital invested

Capital invested by funds: $14.1M → $13M (-$1.04M)

11% less call options, than puts

Call options by funds: $154K | Put options by funds: $173K

13% less funds holding

Funds holding: 47 → 41 (-6)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
13
Closed
9
Calls
$154K
Puts
$173K
Net Calls
-$19K
Net Calls Change
-$159K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$100K
2
Franklin Resources
Franklin Resources
California
+$16.5K
3
U
UBS
Switzerland
+$8.33K
4
GC
Guggenheim Capital
Illinois
+$4.91K
5
BIT
BlackRock Institutional Trust
California
+$4.59K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$661K
2
PAI
Palo Alto Investors
California
-$635K
3
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
-$584K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$195K
5
Barclays
Barclays
United Kingdom
-$119K
Name Holding Trade Value Shares
Change 		Change in
Stake
FIM
26
Freedom Investment Management
Connecticut
$10K -$987 -1,543 -8%
SF
27
Sarofim Fayez
Texas
$9K +$8.87K +13,860 New
BA
28
BlackRock Advisors
Delaware
$8K – – –
RFC
29
Russell Frank Company
Washington
$7K – – –
AL
30
Airain Ltd
Guernsey
$6K -$1.09K -1,700 -14%
Bank of America
31
Bank of America
North Carolina
$6K +$2.28K +3,560 +58%
CPA
32
Cowen Prime Advisors
New York
$3K +$3.49K +5,450 New
PSC
33
Prentiss Smith & Co
Vermont
$1K – – –
Wells Fargo
34
Wells Fargo
California
$1K +$128 +200 +13%
TRCT
35
Tower Research Capital (TRC)
New York
$1K +$1.23K +1,923 New
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
PSAMP
37
P. Schoenfeld Asset Management (PSAM)
New York
– -$584K -1,042,436 Closed
Fidelity Investments
38
Fidelity Investments
Massachusetts
– -$195K -348,908 Closed
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
– -$107K -190,359 Closed
Barclays
40
Barclays
United Kingdom
– -$119K -185,322 -94%
William Blair & Company
41
William Blair & Company
Illinois
– -$95K -170,000 Closed
CD
42
Carl Domino
Florida
– -$70K -124,370 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$68K -120,548 Closed
CCM
44
Coldstream Capital Management
Washington
– -$12K -21,860 Closed
PNC Financial Services Group
45
PNC Financial Services Group
Pennsylvania
– -$7K -11,815 Closed
FWM
46
Focused Wealth Management
New York
– +$192 +300 New
1
2

SVNT Hedge Fund Activity: Q3 2013 in Review

41 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q3 2013, worth a combined $13M — down 7.4% from $14.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SVNT and 5 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 12 added.

The largest buyer was Vanguard Group, adding an estimated $100K. The largest seller was Wellington Management Group, cutting an estimated $661K.

  • 41 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q3 2013, down from 47 in Q2 2013.
  • Funds reported $13M of SAVIENT PHARMACEUTICALS INC stock for Q3 2013, down 7.4% quarter-over-quarter.
  • 5 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q3 2013 and 9 closed out, a net change of -4 holders.
  • The largest SAVIENT PHARMACEUTICALS INC buyer in Q3 2013 was Vanguard Group, an estimated $100K added.
  • The largest SAVIENT PHARMACEUTICALS INC seller in Q3 2013 was Wellington Management Group, an estimated $661K sold.

Based on aggregated 13F filings for Q3 2013.